Dataset Information

Multi-omics approach to characterize sex-specific metabolic alterations in triple-transgenic Alzheimer's mouse brain

ABSTRACT: We aimed to characterise alterations in metabolic pathways and proteome composition in a mouse model of Alzheimer disease (AD). We specifically aimed to evaluate how these differences may be sex-specific by integrative multi-omics analysis (metabolites, lipids, proteins).

INSTRUMENT(S): timsTOF Pro

ORGANISM(S): Mus Musculus (mouse)

TISSUE(S): Brain

DISEASE(S): Alzheimer's Disease

SUBMITTER: Manfredo Quadroni

LAB HEAD: Julijana Ivanisevic

PROVIDER: PXD033164 | Pride | 2023-03-11

REPOSITORIES: Pride

ACCESS DATA

Dataset's files

Source:

			Action	DRS
	916_3-11-2021_Ivanisevic_13020_d10x_DIA_140min_5ul_RB1.d.zip	Other
	917_3-12-2021_Ivanisevic_13022_d10x_DIA_140min_5ul_RB2.d.zip	Other
	918_3-12-2021_Ivanisevic_13023_d10x_DIA_140min_5ul_RB3.d.zip	Other
	919_3-12-2021_Ivanisevic_13025_d10x_DIA_140min_5ul_RB4.d.zip	Other
	920_3-12-2021_Ivanisevic_13027_d10x_DIA_140min_5ul_RB5.d.zip	Other

Items per page:

1 - 5 of 28

Publications

Molecular insights into sex-specific metabolic alterations in Alzheimer's mouse brain using multi-omics approach.

Strefeler Abigail A Jan Maxime M Quadroni Manfredo M Teav Tony T Rosenberg Nadia N Chatton Jean-Yves JY Guex Nicolas N Gallart-Ayala Hector H Ivanisevic Julijana J

Alzheimer's research & therapy 20230109 1

<h4>Background</h4>Alzheimer's disease (AD) is a progressive neurodegenerative disorder that is characterized by altered cellular metabolism in the brain. Several of these alterations have been found to be exacerbated in females, known to be disproportionately affected by AD. We aimed to unravel metabolic alterations in AD at the metabolic pathway level and evaluate whether they are sex-specific through integrative metabolomic, lipidomic, and proteomic analysis of mouse brain tissue.<h4>Methods< ...[more]

PMID: 36624525

Similar Datasets

Project description:Objective: Athletes increasingly engage in repeated sprint training that consists of repeated short all-out effort interspersed by short periods of recovery. When performed in hypoxia (RSH), it may lead to greater training effects than in normoxia (RSN), however the underlying molecular mechanisms remain unclear. This study aimed at elucidating the effects of RSH on skeletal muscle oxidative and glycolytic adaptations as compared to RSN. Methods: Healthy young men performed nine repeated sprint training sessions in three weeks. Each training session consisted in six series of six sprints in either normoxia (FiO2 = 20.9%, RSN, n = 7) or normobaric hypoxia (FiO2 = 13.6%, RSH, n = 9). Before and after the training period, exercise performance was assessed by using repeated sprint ability (RSA) and Wingate tests. Vastus lateralis muscle biopsies were performed to investigate muscle metabolic adaptations using proteomic combined to western blotting analyses. Results: We observed similar improvements in RSA and Wingate tests in both RSH and RSN groups. Proteomic analysis revealed a decrease in several proteins involved in oxidative phosphorylation (OXPHOS) in both groups and this was confirmed with western blot showing significant reductions in complexes I and V protein levels. RSN and RSH increased protein levels of the glycolytic enzyme hexokinase II, while only RSH induced a significant increase in the glucose transporter 4 (GLUT4) protein levels, suggesting superior glycolytic adaptations in response to hypoxia. This phenotype is further supported by proteomics data showing significant increase of proteins involved in glycolysis. Our proteomics data showed in the RSH group a specific increase in several S100A family proteins, among which S100A13 was the most modified, a result confirmed by western blot. S100A proteins have recently been shown to accelerate glycolytic phenotype of cancer cells by activating the protein kinase B (Akt) pathway. Our data corroborate these findings by showing in RSH group increased Akt phosphorylation as well as increased levels of proteins related to Akt downstream effects such as enhanced translation. Conclusions: Altogether our data indicate that RSH, as compared to RSN, potentiates the muscle glycolytic phenotype, possibly through the activation of S100A13 and the Akt pathway.